Are you PrEP(ared)? PrEP Basics & Knowledge Dissemination

Size: px
Start display at page:

Download "Are you PrEP(ared)? PrEP Basics & Knowledge Dissemination"

Transcription

1 Are you PrEP(ared)? PrEP Basics & Knowledge Dissemination Harlan Pruden Educator, Chee Mamuk, Aboriginal Program BC Center for Disease Control, Clinical Prevention Services Sḵwx on the traditional, ancestral and unceeded territory of the wú7mesh Úxwumixw, Tsleil-Waututh and xwməθkwəy əm First Nations UBC Learning Circle's Centre for Excellence in Indigenous Health Presentation 13, February, 2018

2 Disclosures As of February 2018, I have no conflicts of interest to declare. 2

3 Objectives: Discussion from a First Nations and Inuit People lens: What is PrEP? Who is PrEP for? Accessing publicly-funded PrEP in BC and in Canada Resources 3

4 Chee Mamuk Team: Felicia Tebb Ojibwe Administrative & Community Support Jessica Chenery Penelakut Program Lead Michael McCarthy Yuʔłuʔiłʔath Educator Lynette La Fontaine Metis Nurse Educator Harlan Pruden Cree Educator Amanda Porter St uxtews Nurse Educator (on maternity leave) 4

5 Chee Mamuk provides innovative and culturally appropriate HIV, Hepatitis and STI education, resources and wise practice models for and with Aboriginal communities. This is accomplished by the following: o Around the Kitchen Table o Encouraging Strong Paths o Two-Spirit Program o Creating Community Relevant Resources 5

6 6 The Chee Mamuk tree serves as our theoretical understanding. The post-its, on our tree provide a visual road map to guide our current work load.

7 The HIV Combination Prevention Toolbox Post-Exposure Prophylaxis (PEP) Pre-Exposure Prophylaxis (PrEP) Prevention of Motherto-Child Transmission (PMTCT) Vaccines HIV Prevention Toolbox Medical Treatment as Prevention (TasP) Microbicides Sexually Transmitted Infections (STIs) Diagnosis and Treatment Clean Syringes (Needle Exchange Programs) Condoms and Other Barrier Methods Behavioral/Physical Barriers Harm Reduction Education Treatment/ Prevention of Drug/ Alcohol Abuse 7

8 Comprehensive HIV prevention includes multiple approaches instead of just one or two approaches. 8

9 9

10 No one HIV prevention approach will be acceptable to all people. Research is critical to develop and test new prevention options that offer people more choices. The best option for one person may not be the best for others. 10

11 npep vs. PrEP PrEP: treatment before exposure HIV Exposure PEP: treatment after exposure 11

12 Post-Exposure Prophylaxis (PEP) Pre-Exposure Prophylaxis (PrEP) Prevention of Motherto-Child Transmission (PMTCT) Vaccines HIV Prevention Toolbox Medical Treatment as Prevention (TasP) Microbicides Sexually Transmitted Infections (STIs) Diagnosis and Treatment Clean Syringes (Needle Exchange Programs) Condoms and Other Barrier Methods Behavioral/Physical Barriers Harm Reduction Education Treatment/ Prevention of Drug/ Alcohol Abuse 12

13 The PrEP prevention approach is focused on people who do not have HIV, but may be at risk of exposure to HIV through sexual contact and/or injection drug use (IDU) With PrEP, people who do not have HIV receive a prescription for a medication. The medication is a pill, taken once again a day. The medication may lower their risk of HIV transmission if they are exposed to HIV. 13

14 PrEP Progress in Canada Ø Ø Ø Ø Ø In 2006, the co-formulation of emtricitabine/tenofovir (trade name: Truvada) received its Notice of Compliance (NOC) from Health Canada for the treatment of HIV-1 infection. In 2007, Truvada listed as a Non-Insured Health Benefits (NIHB) benefit for treatment of HIV-1 infection. The NIHB provides coverage to eligible residents of Canada who are either: a First Nations person who is registered under the Indian Act; an Inuk recognized by an Inuit land claim organization; or an infant less than 1 year old whose parent is a registered First Nations person or a recognized Inuk. In BC, the First Nations Health Authority (FNHA) began receiving transfer payments from Health Canada for the NIHB program on July 2, Truvada, as a treatment, was covered by FNHA. Feb. 6, 2016 Health Canada issued an NOC for Truvada, in combination with safer sex practices, for the preventive indication of pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in HIV-negative adults at risk. FNHA followed Health Canada and began to cover PrEP. 14

15 HIV Prevention Using Truvada Truvada is a combination of two antiretroviral drugs: Tenofovir disoproxil fumarate (also called TDF, or tenofovir) Emtricitabine (also called FTC) Truvada is approved for daily use for HIV prevention. Truvada must be taken on a consistent, daily basis to be effective as PrEP. PrEP is NOT effective in preventing other STBBI including: syphilis, gonorrhea or hepatitis It is recommended that people who are prescribed PrEP and to be used as a combination prevention strategy that includes behavioural interventions and other strategies from the medicine wheel. 15

16 HIV Prevention Using Truvada, continued How Truvada as PrEP works Truvada is an antiretroviral medication (ARV) that protects HIV-negative people from acquiring HIV if they are exposed to the virus ARVs block the action of a protein that HIV needs to infect the body 16

17 HIV Prevention Using Truvada, continued Who should use Truvada for HIV prevention? Male-assigned Two-Spirit and/or Native men who have sex with men Transgender women who have sex with men Heterosexual couples where one partner has HIV and the other does not People Who Inject Drugs (PWID) 17

18 Accessing Truvada, here in BC Requirements for use Be HIV negative proven by testing prior to starting use (4th generation HIV Ag/Ab test) Other baseline bloodwork is required: Hepatitis B surface antigen (HBsAg), creatinine, and estimated glomerular filtration rate (egfr) Ongoing testing for HIV infection at least every 3 months while taking Truvada 18

19 Accessing Truvada, here in BC First Nations & Inuit People in BC and the rest of Canada 1st appointment/visit: Baseline bloodwork 2nd appointment/visit: Based on a review of baseline bloodwork, Truvada prescribed 3rd appointment/visit: Prescription is filled at no coast at any pharmacy. 19

20 Accessing Truvada, here in BC General Population including Metis People in BC (Non-Inuit & First Nations People) 1st appointment/visit: PrEP is requested and baseline bloodwork ordered 2nd appointment/visit: Based on a review of baseline bloodwork, prescriber completes CfE form and submitted for approval (up to 2 business days). PrEP medication is prescribed. 3 rd appointment/visit: PrEP prescription is filled at St Paul's Hospital Ambulatory Pharmacy Burrard Street, Vancouver Outside of Vancouver 3 rd appointment/visit: Prescriber arranges for PrEP prescription to be filled at St. Paul s and sent to their office for dispensing 20

21 PrEP Summary PrEP is a medical prevention approach for people who do not have HIV but are at risk for HIV infection. They take a specific medication on a daily basis to reduce the risk of HIV infection if exposed through sexual contact and/or intravenous drug use. 21

22 PrEP Summary continued: 22

23 For More Information SOCIAL MEDIA AND ONLINE COMMUNITIES: PrEP Canada: Rethinking HIV Prevention - PrEP Facts: Rethinking HIV Prevention and Sex OTHER RESOURCES: BC Centre for Disease Control s SmartSexResource.com search PrEP for more information BC Centre for Excellence in HIV/AIDS HIV Drug Treatment program information CATIE.ca Pre-exposure prophylaxis (PrEP) GETPrEPED PrEP information website for BC from the Health Initiative for Men The Sex You Want PrEP information for gay and bisexual men (Torontobased) US Centres for Disease Control and Prevention Pre-exposure prophylaxis (PrEP) 23

24 Discussion and Questions? And Thank You So Much! 24

PrEP for HIV Prevention. Adult Clinical Guideline from the New York State Department of Health AIDS Institute

PrEP for HIV Prevention. Adult Clinical Guideline from the New York State Department of Health AIDS Institute PrEP for HIV Prevention Adult Clinical Guideline from the New York State Department of Health AIDS Institute www.hivguidelines.org Purpose of the PrEP Guideline Raise awareness of PrEP among healthcare

More information

Disclosure. Learning Objectives. Epidemiology. Transmission. Risk of Transmission PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION 50,000.

Disclosure. Learning Objectives. Epidemiology. Transmission. Risk of Transmission PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION 50,000. Disclosure PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION I have no financial interest in and/or affiliation with any external organizations in relation to this CE program. DaleMarie Vaughan, PharmD

More information

PrEP for Women: HIV Prevention in Family Planning Settings

PrEP for Women: HIV Prevention in Family Planning Settings National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention PrEP for Women: HIV Prevention in Family Planning Settings Dawn K. Smith, MD, MS, MPH Division of HIV/AIDS Prevention dsmith1@cdc.gov

More information

HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland. An update for registered practitioners September 2017

HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland. An update for registered practitioners September 2017 HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland An update for registered practitioners September 2017 Key Messages HIV is a major public health challenge for Scotland with an annual average of 359

More information

Attendees will be able to:

Attendees will be able to: A. Kay Kalousek, DO, MS, FACOFP kaysdroid@gmail.com April 21, 2017 Attendees will be able to: List strategies for prevention of HIV infection Explain the pharmacology of TDF/FTC related to PrEP Assess

More information

PrEP: Getting to the Tipping Point

PrEP: Getting to the Tipping Point PrEP: Getting to the Tipping Point Harvey J Makadon, MD The National LGBT Health Education Center, The Fenway Institute Professor of Medicine, Harvard Medical School April 15, 2016 Continuing Medical Education

More information

On the Horizon for Consideration: Biomedical Advances in HIV Prevention

On the Horizon for Consideration: Biomedical Advances in HIV Prevention On the Horizon for Consideration: Biomedical Advances in HIV Prevention Francisco Ruiz, MS Senior Manager, National Alliance of State and Territorial AIDS Directors New Jersey Governor's Advisory Council

More information

OR: Steps you can take in the clinic to prevent HIV infections

OR: Steps you can take in the clinic to prevent HIV infections Implementing Changes to Reduce HIV Incidence: Synergies between Public Health and Primary Care Kevin Ard, MD, MPH Brigham and Women s Hospital, Massachusetts General Hospital, and the Fenway Institute

More information

Using PrEP as Harm Reduction. Iman Little, MPH Team Lead, Preventative Services Chicago Center for HIV Elimination

Using PrEP as Harm Reduction. Iman Little, MPH Team Lead, Preventative Services Chicago Center for HIV Elimination Be PrEPared! Using PrEP as Harm Reduction Iman Little, MPH Team Lead, Preventative Services Chicago Center for HIV Elimination Ricky Hill, MA, PhD candidate Team Lead, Community Partnerships and Engagement

More information

Pre-Exposure Prophylaxis (PrEP) Stefanie La Manna, PhD, MPH, APRN, FNP-C, AGACNP-BC October 12, 2018

Pre-Exposure Prophylaxis (PrEP) Stefanie La Manna, PhD, MPH, APRN, FNP-C, AGACNP-BC October 12, 2018 Pre-Exposure Prophylaxis (PrEP) Stefanie La Manna, PhD, MPH, APRN, FNP-C, AGACNP-BC October 12, 2018 Disclosures I have no financial disclosures to report Objectives Identify the need for HIV prevention

More information

Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft:

Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft: Guidelines for Implementing Pre-Exposure Prophylaxis For The Prevention of HIV in Youth Peter Havens, MD MS Draft: 10-2-2015 Clinical studies demonstrate that when a person without HIV infection takes

More information

PrEPX frequently asked questions version 1

PrEPX frequently asked questions version 1 1 PrEPX FAQs version 1 This document will be published on the Alfred Health PrEPX webpage and as a printed hand out for potential study participants. What is HIV PrEP? Pre-Exposure Prophylaxis (PrEP) is

More information

PREVENTION OF HIV IN THE TIMES OF PREP. Daniela Chiriboga, MD Florida Department of Health in Polk County

PREVENTION OF HIV IN THE TIMES OF PREP. Daniela Chiriboga, MD Florida Department of Health in Polk County PREVENTION OF HIV IN THE TIMES OF PREP Daniela Chiriboga, MD Florida Department of Health in Polk County MAKING THE CASE FOR PREVENTION The Epidemic in Florida Population in 2014: 19.6 million (3 rd in

More information

PrEP: Pre Exposure Prophylaxis

PrEP: Pre Exposure Prophylaxis PrEP: Pre Exposure Prophylaxis Lyn Stevens, NP, MS, ACRN Deputy Director Office of the Medical Director NYS Department of Health, AIDS Institute Faculty Disclosure Lyn Stevens No relationships to disclose

More information

Strategic use of antiretroviral drugs to prevent HIV transmission

Strategic use of antiretroviral drugs to prevent HIV transmission Strategic use of antiretroviral drugs to prevent HIV transmission 22th Tunisian Congress of Infectious Diseases 2nd Congress of Federation of Arab Societies of Clinical Microbiology and Infectious Diseases

More information

PrEP for Women. Together, we can change the course of the HIV epidemic one woman at a time.

PrEP for Women. Together, we can change the course of the HIV epidemic one woman at a time. PrEP for Women Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What Is PrEP? PrEP stands for Pre- Exposure Prophylaxis: Prophylaxis: Taking

More information

Pre exposure Prophylaxis (PrEP): Stepping Up HIV Prevention

Pre exposure Prophylaxis (PrEP): Stepping Up HIV Prevention Pre exposure Prophylaxis (PrEP): Stepping Up HIV Prevention Dawn K. Smith, MD, MS, MPH Centers for Disease Control and Prevention The findings and conclusions in this presentation have not been formally

More information

How to order generic PrEP online Find a doctor who prescribes PrEP Learn how to prescribe PrEP Information for doctors. What is PrEP?

How to order generic PrEP online Find a doctor who prescribes PrEP Learn how to prescribe PrEP Information for doctors. What is PrEP? 4 What is PrEP? 6 Who will benefit from PrEP? 7 Men (cis or trans) and trans women who have sex with men Partners of people living with HIV 8 Take the quiz: Is PrEP right for me? What are the options for

More information

Pre-Exposure Prophylaxis (PrEP) A Biomedical Intervention Prevention with Negatives Antiretroviral Prevention

Pre-Exposure Prophylaxis (PrEP) A Biomedical Intervention Prevention with Negatives Antiretroviral Prevention Pre-Exposure Prophylaxis (PrEP) A Biomedical Intervention Prevention with Negatives Antiretroviral Prevention New and Emerging Biomedical HIV Prevention Interventions Vaccines Vaginal microbicides Pre-exposure

More information

-decreased bone Adherence iprex study. -protective effect

-decreased bone Adherence iprex study. -protective effect HIV Pre-Exposure Prophylaxi is (PrEP): A brief guide for providers Daily emtricitabine/tenofovir (Truvada ) is safe and effectivee for reducing the risk of HIV acquisition in sexually active men and women

More information

Combination HIV Prevention Research Carl W. Dieffenbach, Ph.D.

Combination HIV Prevention Research Carl W. Dieffenbach, Ph.D. Combination HIV Prevention Research Carl W. Dieffenbach, Ph.D. Director, Division of AIDS, NIAID, NIH October 13, 2011 Multiple strategies needed to assemble a wellrounded prevention toolkit Know the epidemics

More information

Pre-exposure prophylaxis (PrEP)

Pre-exposure prophylaxis (PrEP) FACTSHEET Pre-exposure prophylaxis (PrEP) Summary Pre-exposure prophylaxis, or PrEP, is a way for an HIV-negative person who is at risk of HIV infection to reduce their risk of becoming infected with HIV.

More information

PrEP in Scotland. PrEP. in Scotland. PrEP. PrEP. PrEP. PrEP is a combination pill that prevents HIV.

PrEP in Scotland. PrEP. in Scotland. PrEP. PrEP. PrEP. PrEP is a combination pill that prevents HIV. PrEP in Scotland PrEP PrEP PrEP PrEP is a combination pill that prevents HIV. 1 Contents Introduction 3 What is PrEP 3 Who should take PrEP 4 Getting PrEP in Scotland 5 Side effects and interactions with

More information

Around The Kitchen Table

Around The Kitchen Table Around The Kitchen Table Chee Mamuk, Aboriginal Program, at the BC Centre for Disease Control provides culturally appropriate HIV/AIDS and sexually transmitted infection (STI) education to Aboriginal communities

More information

I M ENDING HIV PATIENT INFORMATION. endinghiv.org.au/prep

I M ENDING HIV PATIENT INFORMATION. endinghiv.org.au/prep I M ENDING HIV PrEP PATIENT INFORMATION endinghiv.org.au/prep THIS BOOKLET PROVIDES YOU WITH INFORMATION ABOUT Pre-Exposure Prophylaxis (PrEP) for HIV. CONTENTS 06 Who will benefit from PrEP? 04 What is

More information

The HIV Prevention Pill: The State of PrEP Science and Implementation

The HIV Prevention Pill: The State of PrEP Science and Implementation The HIV Prevention Pill: The State of PrEP Science and Implementation James Wilton Coordinator, Biomedical Science of HIV Prevention CATIE December 11 th, 2014 Overview 1. The Basics 2. A review of the

More information

Pre-exposure Prophylaxis and Primary Care

Pre-exposure Prophylaxis and Primary Care Pre-exposure Prophylaxis and Primary Care National Latino HIV and Hepatitis C Conference June 7 th, 2016 Allison Finkenbinder, MSN, WHNP-BC Denver Prevention Training Center Who s in the audience? Disclosures

More information

CONTENTS. New Zealand s personal importation scheme for medicines. What is PrEP? Who will benefit from PrEP? Sex between men

CONTENTS. New Zealand s personal importation scheme for medicines. What is PrEP? Who will benefit from PrEP? Sex between men CONTENTS 4 What is PrEP? 6 Who will benefit from PrEP? Sex between men 7 Sex between men and women 8 What happens when I start on PrEP? 9 What if I want to stop using PrEP? Where can I get PrEP in New

More information

HIV Prevention Strategies HIV Pre-exposure prophylaxis

HIV Prevention Strategies HIV Pre-exposure prophylaxis HIV Prevention Strategies HIV Pre-exposure prophylaxis Michael Martin, MD, MPH Director HIV Research Program Thailand MOPH U.S. CDC Collaboration The findings and conclusions in this presentation are those

More information

Welcome to the National Association of County and City Health Officials Webinar on PrEP and Local Health Departments

Welcome to the National Association of County and City Health Officials Webinar on PrEP and Local Health Departments Welcome to the National Association of County and City Health Officials Webinar on PrEP and Local Health Departments There are two options for accessing the audio portion of this webinar: (1) Using your

More information

Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP)

Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Important Safety Information About Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) For Healthcare Providers About Emtricitabine/Tenofovir Disoproxil

More information

Important Safety Information for Adolescents Who Don t Have HIV

Important Safety Information for Adolescents Who Don t Have HIV Important Safety Information for Adolescents Who Don t Have HIV This booklet tells you about: HIV The medicine emtricitabine/tenofovir disoproxil fumarate for HIV-1 PrEP What you need to do while taking

More information

Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Training Guide for Healthcare Providers

Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Training Guide for Healthcare Providers Emtricitabine/Tenofovir Disoproxil Fumarate 200 mg/300 mg for HIV-1 Pre-exposure Prophylaxis (PrEP) Training Guide for Healthcare Providers About emtricitabine/tenofovir disoproxil fumarate for HIV-1 PrEP

More information

South African Guidelines for the Safe Use of. Dr. Oscar Radebe

South African Guidelines for the Safe Use of. Dr. Oscar Radebe South African Guidelines for the Safe Use of PrEP in MSM Dr. Oscar Radebe Background Globally MSM(men who have sex with men) have been disproportionately at high risk of HIV transmission. Biological &

More information

PrEP and npep for HIV Prevention. Harry Rosado-Santos MD, FACP Associate Professor UU School of Medicine

PrEP and npep for HIV Prevention. Harry Rosado-Santos MD, FACP Associate Professor UU School of Medicine PrEP and npep for HIV Prevention Harry Rosado-Santos MD, FACP Associate Professor UU School of Medicine Case Study A 26 y/o M presents for routine asymptomatic screening for sexually transmitted infections

More information

HIV PREP THE NEWEST TOOL IN THE BOX

HIV PREP THE NEWEST TOOL IN THE BOX HIV PREP THE NEWEST TOOL IN THE BOX Infectious Disease Update November 7, 2014 Andrew Petroll, MD, MS Department of Medicine, Division of Infectious Diseases Department of Psychiatry and Behavioral Medicine,

More information

Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world?

Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world? Antiretroviral Drugs for HIV Seronegative People: It works in trials, what about the real world? Lut Van Damme 11 Oct 2012 1 Disclaimer Gilead donated the study product for the FEM-PrEP trial I participated

More information

The HIV Prevention Pill: The State of PrEP Science and Implementation. James Wilton Coordinator, Biomedical Science of HIV Prevention CATIE

The HIV Prevention Pill: The State of PrEP Science and Implementation. James Wilton Coordinator, Biomedical Science of HIV Prevention CATIE The HIV Prevention Pill: The State of PrEP Science and Implementation James Wilton Coordinator, Biomedical Science of HIV Prevention CATIE Overview 1. The Basics 2. A review of the science 3. An update

More information

Important Safety Information About TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. For Healthcare Providers

Important Safety Information About TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. For Healthcare Providers Important Safety Information About TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication For Healthcare Providers About TRUVADA for a PrEP Indication INDICATION AND PRESCRIBING CONSIDERATIONS TRUVADA,

More information

Government of Canada Federal AIDS Initiative Milestones

Government of Canada Federal AIDS Initiative Milestones HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for

More information

Recent Breakthroughs in HIV Prevention for Men who Have Sex with Men and Transgender Populations

Recent Breakthroughs in HIV Prevention for Men who Have Sex with Men and Transgender Populations Recent Breakthroughs in HIV Prevention for Men who Have Sex with Men and Transgender Populations Kevin Ard, MD, MPH Brigham and Women s Hospital The Fenway Institute Boston, MA Funding: The New England

More information

SFAF CLINICAL PROTOCOLS

SFAF CLINICAL PROTOCOLS SFAF CLINICAL PROTOCOLS Page 1 of Supersedes Date: December 31, 2016 Original Date: August 20, 2014 Version: 03 Policy Section: Patient Care Non-Occupational Post Exposure Prophylaxis Program Back ground:

More information

Providing Good Care to People Living with HIV

Providing Good Care to People Living with HIV National Ambulance LGBT Network Providing Good Care to People Living with HIV An Ambulance Service Resource Pack Supporting Lesbian, Gay, Bisexual, Trans staff, patients and communities A partnership of

More information

HIV PrEP in Ireland. Information booklet for people who are accessing PrEP themselves or are considering accessing PrEP

HIV PrEP in Ireland. Information booklet for people who are accessing PrEP themselves or are considering accessing PrEP HIV PrEP in Ireland Information booklet for people who are accessing PrEP themselves or are considering accessing PrEP The HSE Sexual Health and Crisis Pregnancy Programme (SHCPP) and the HIV PrEP working

More information

Biomedical Prevention in HIV

Biomedical Prevention in HIV Biomedical Prevention in HIV CHART - CCAS-CDC 3 RD Joint Meeting Montego Bay, Jamaica August 21-26,2011 Presented by Tina Hylton-Kong, ERTU-CHART Some Slides from Impact of ART on HIV Transmission Wafaa

More information

ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF

ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF PrEP MTN Regional Meeting Cape Town 20 September 2017 Dhevium Govender South African Medical Research Council HIV Prevention Research Unit Quality/Regulatory

More information

Pre Exposure Prophylaxis Health Program

Pre Exposure Prophylaxis Health Program MAGNET CLINICAL PROTOCOLS Pre Exposure Prophylaxis Health Program Page 1 of Supersedes Date: October 7, 2018 Original Date: August 20, 2014 Version: 09 Policy Section: Patient Care Back ground: The advent

More information

PEP/PrEP Update A BC Case Study

PEP/PrEP Update A BC Case Study PEP/PrEP Update A BC Case Study Dr. Mark Hull MHSc FRCPC Clinical Associate Professor Division of AIDS University of British Columbia Joshua Edward, Program Manager, Knowledge Translation, Health Initiative

More information

TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. Training Guide for Healthcare Providers

TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication. Training Guide for Healthcare Providers TRUVADA for a Pre-exposure Prophylaxis (PrEP) Indication Training Guide for Healthcare Providers About TRUVADA for a PrEP indication to reduce the risk of sexually acquired HIV-1 infection in high-risk

More information

Moving beyond condoms to prevent HIV transmission. Are you Prepared for HIV PrEP?

Moving beyond condoms to prevent HIV transmission. Are you Prepared for HIV PrEP? Moving beyond condoms to prevent HIV transmission Are you Prepared for HIV PrEP? The Issues New HIV infections in the US continue Vast majority of infections are sexually acquired Condoms work but are

More information

Ending HIV and Australia s success story in PrEP implementation Dr Heather-Marie Schmidt

Ending HIV and Australia s success story in PrEP implementation Dr Heather-Marie Schmidt Ending HIV and Australia s success story in PrEP implementation Dr Heather-Marie Schmidt BBV and STI Unit Centre for Population Health NSW Ministry of Health Session overview 1. Background: HIV & Healthcare

More information

8/25/2016. Making Preexposure Prophylaxis Available in the Clinic: Considerations and Pathways Forward

8/25/2016. Making Preexposure Prophylaxis Available in the Clinic: Considerations and Pathways Forward WORKSHOP SESSION: MAKING PREEXPOSURE PROPHYLAXIS AVAILABLE IN THE CLINIC: CONSIDERATIONS AND PATHWAYS FORWARD PRE-REGISTRATION IS REQUIRED PLEASE SEE THE CPT INFORMATION DESK IF THIS IS NOT YOUR SELECTED

More information

HIV PREVENTION WITH PRE-EXPOSURE PROPHYLAXIS: A PRIMER FOR PHARMACISTS. Speaker: Susan MK Lee, PharmD, BCPS, CDE

HIV PREVENTION WITH PRE-EXPOSURE PROPHYLAXIS: A PRIMER FOR PHARMACISTS. Speaker: Susan MK Lee, PharmD, BCPS, CDE Clinical Education Initiative Support@ceitraining.org HIV PREVENTION WITH PRE-EXPOSURE PROPHYLAXIS: A PRIMER FOR PHARMACISTS Speaker: Susan MK Lee, PharmD, BCPS, CDE 12/13/2016 HIV Prevention with Pre-Exposure

More information

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines

Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines GUIDELINES Journal of Virus Eradication 2017; 3: 168 184 Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine HIV pre-exposure prophylaxis: clinical guidelines Edwina Wright 1 3 *,

More information

About FEM-PrEP. FEM-PrEP is also studying various behaviors, clinical measures, and health outcomes among the trial s participants.

About FEM-PrEP. FEM-PrEP is also studying various behaviors, clinical measures, and health outcomes among the trial s participants. Fact Sheet About FEM-PrEP What is the FEM-PrEP clinical trial? FEM-PrEP is a Phase III randomized, placebo-controlled, clinical trial designed to assess the safety and effectiveness of a daily oral dose

More information

Getting to Zero in California: Integration of HIV Prevention and Surveillance

Getting to Zero in California: Integration of HIV Prevention and Surveillance Getting to Zero in California: Integration of HIV Prevention and Surveillance Steve Gibson, MSW and Deanna Sykes, PhD CDPH, Office of AIDS November 27, 2017 Learning Objectives Understand reasons for integrated

More information

ART and Prevention: What do we know?

ART and Prevention: What do we know? ART and Prevention: What do we know? Biomedical Issues Trip Gulick, MD, MPH Chief, Division of Infectious Diseases Professor of Medicine Weill Cornell Medical College New York City ART for Prevention:

More information

PrEP in the Real World: Clinical Case Studies

PrEP in the Real World: Clinical Case Studies PrEP in the Real World: Clinical Case Studies Kevin L. Ard, MD, MPH April 30, 2015 Massachusetts General Hospital, National LGBT Health Education Center Continuing Medical Education Disclosure Program

More information

PrEP Home Checklist v1.0

PrEP Home Checklist v1.0 PrEP Home Checklist v1.0 Every Visit o Risk Reduction Counseling o Appropriate referrals and follow-ups (SW, Pharmacy, et al.) o For those on PrEP: o Assessment of PrEP adherence, side effects, ongoing

More information

PrEP: Preexposure Prophylaxis to prevent HIV Lisa Pietrusza, BSN, RN FNP-DNP student, University of Pittsburgh Nov. 3, 2017.

PrEP: Preexposure Prophylaxis to prevent HIV Lisa Pietrusza, BSN, RN FNP-DNP student, University of Pittsburgh Nov. 3, 2017. PrEP: Preexposure Prophylaxis to prevent HIV Lisa Pietrusza, BSN, RN FNP-DNP student, University of Pittsburgh Nov. 3, 2017 Disclosures The views expressed heroine do not necessarily reflect the official

More information

PrEP 201: Beyond the Basics

PrEP 201: Beyond the Basics NORTHWEST AIDS EDUCATION AND TRAINING CENTER PrEP 201: Beyond the Basics Joanne Stekler, MD MPH Associate Professor of Medicine University of Washington February 19, 2015 Disclosures and Disclaimers I

More information

Fast-Track Your PrEP Knowledge. Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs

Fast-Track Your PrEP Knowledge. Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs Fast-Track Your PrEP Knowledge Jonathan Fritz PrEP Coordinator MDHHS Division of HIV and STD Programs Session objectives Increase knowledge of the basics of PrEP and clinical procedures Identify financial

More information

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs Aljona Kurbatova National Institute for Health Development Estonia Estimated number of people who inject

More information

HIV. The Role of Pre-Exposure Prophylaxis (PrEP) for the Prevention of HIV. Brief History of HIV AIDS. Global HIV Infection.

HIV. The Role of Pre-Exposure Prophylaxis (PrEP) for the Prevention of HIV. Brief History of HIV AIDS. Global HIV Infection. The Role of Pre-Exposure Prophylaxis (PrEP) for the Prevention of HIV HIV Sarah Kemink, PharmD, AAHIVP WMSHP Spring Seminar 5/05/2015 AIDS CD4 less than 200 +/- AIDS-defining illness Most common: Candidiasis

More information

Clinical Commissioning Policy Proposition: Pre-exposure prophylaxis (PrEP) to prevent the acquisition of HIV in adults

Clinical Commissioning Policy Proposition: Pre-exposure prophylaxis (PrEP) to prevent the acquisition of HIV in adults Clinical Commissioning Policy Proposition: Pre-exposure prophylaxis (PrEP) to prevent the acquisition of HIV in adults Reference: NHS England F03X06 First published: TBC Prepared by NHS England Specialised

More information

The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint

The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint The current status of PrEP in Europe Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint DISCLOSURES I have received a research grant from Gilead Sciences awarded to my institution

More information

HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland

HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland HIV Pre-Exposure Prophylaxis (HIV PrEP) in Scotland An update for registered practitioners November 2017 Rationale for resource This resource is designed to support registered practitioners involved in

More information

Multiple choice questions: ANSWERS

Multiple choice questions: ANSWERS Multiple choice questions: ANSWERS Chapter 1. Diagnosis and promotion of serostatus awareness in sub-saharan Africa 1. Antiretroviral therapy reduces HIV transmission from a HIV- positive person to a susceptible

More information

FRAMEWORK DOCUMENT. New HIV Prevention Technologies: Regulatory, policy, programming and research implications for Canada.

FRAMEWORK DOCUMENT. New HIV Prevention Technologies: Regulatory, policy, programming and research implications for Canada. FRAMEWORK DOCUMENT New HIV Prevention Technologies: Regulatory, policy, programming and research implications for Canada November 2011 Developed by: With financial support from: Table of Contents Table

More information

The role of Integrase Inhibitors during HIV prevention

The role of Integrase Inhibitors during HIV prevention The role of Integrase Inhibitors during HIV prevention Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint 2nd Global HIV Clinical Forum: Integrase Inhibitors Paris July 22th

More information

An International Antiviral Society-USA

An International Antiviral Society-USA Doug Campos-Outcalt, MD, MPA University of Arizona, Phoenix dougco@email.arizona. edu A look at new guidelines for HIV treatment and prevention Start antiretroviral therapy as soon as possible after HIV

More information

Pre-Exposure Prophylaxis (PrEP) for HIV Infection

Pre-Exposure Prophylaxis (PrEP) for HIV Infection Pre-Exposure Prophylaxis (PrEP) for HIV Infection Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health University of California Los Angeles Attending Physician UCLA Center AIDS Research

More information

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS

HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS POLICY BRIEF HIV PREVENTION, DIAGNOSIS, TREATMENT AND CARE FOR KEY POPULATIONS CONSOLIDATED GUIDELINES JULY 2014 Policy brief: Consolidated guidelines on HIV prevention, diagnosis, treatment and care for

More information

Pre-Exposure Prophylaxis Perspectives from the Southeast. Christopher Hurt, MD Assistant Professor of Medicine Division of Infectious Diseases

Pre-Exposure Prophylaxis Perspectives from the Southeast. Christopher Hurt, MD Assistant Professor of Medicine Division of Infectious Diseases Pre-Exposure Prophylaxis Perspectives from the Southeast Christopher Hurt, MD Assistant Professor of Medicine Division of Infectious Diseases Disclosures I have no actual or potential conflicts of interest

More information

Inspiring HIV Prevention Innovations for Women. IPM Satellite Event Durban, 13 th June 2017 Annalene Nel

Inspiring HIV Prevention Innovations for Women. IPM Satellite Event Durban, 13 th June 2017 Annalene Nel Inspiring HIV Prevention Innovations for Women IPM Satellite Event Durban, 13 th June 2017 Annalene Nel HIV Infection: Where We Are Today 30+ years since the US CDC reported the first cases of AIDS 25.5

More information

CATIE STATEMENT. on the use of oral pre-exposure prophylaxis (PrEP) as a highly effective strategy to prevent the sexual transmission of HIV

CATIE STATEMENT. on the use of oral pre-exposure prophylaxis (PrEP) as a highly effective strategy to prevent the sexual transmission of HIV CATIE STATEMENT on the use of oral pre-exposure prophylaxis (PrEP) as a highly effective strategy to prevent the sexual transmission of HIV The consistent and correct use of oral Truvada as pre-exposure

More information

Drug development in relation to PrEP and the PROUD study

Drug development in relation to PrEP and the PROUD study Drug development in relation to PrEP and the PROUD study David Dolling Medical Statistician MRC Clinical Trials Unit 18 th October 2012 What is PrEP? - Pre-exposure Prophylaxis A strategy that uses antiretrovirals

More information

Gilead Announces Data Demonstrating Non-Inferiority of Once-Daily Descovy vs. Once-Daily Truvada for Prevention of HIV Infection

Gilead Announces Data Demonstrating Non-Inferiority of Once-Daily Descovy vs. Once-Daily Truvada for Prevention of HIV Infection Gilead Announces Data Demonstrating Non-Inferiority of Once-Daily Descovy vs. Once-Daily Truvada for Prevention of HIV Infection March 6, 2019 DISCOVER Trial Meets Primary and Secondary Endpoints and Will

More information

Pre-Exposure Prophylaxis (PrEP): Best Practices for Pharmacists

Pre-Exposure Prophylaxis (PrEP): Best Practices for Pharmacists Pre-Exposure Prophylaxis (PrEP): Best Practices for Pharmacists Tina J Kanmaz, PharmD, AAHIVE Associate Clinical Professor Assistant Dean, Experiential Pharmacy Education St. John s University College

More information

PREPARING FOR PrEP: SCIENCE, RESEARCH, AND ACCESS. September 29, :00 PM EST

PREPARING FOR PrEP: SCIENCE, RESEARCH, AND ACCESS. September 29, :00 PM EST PREPARING FOR PrEP: SCIENCE, RESEARCH, AND ACCESS September 29, 2016 1:00 PM EST DISCLAIMER This webinar is supported by Cooperative Agreement 5U87PS004223-04 and 5U87PS004164, funded by the Centers for

More information

Guidelines for PrEP in PWID

Guidelines for PrEP in PWID Guidelines for PrEP in PWID Any use of injection drugs (past 6 months) AND Any sharing of injection equipment OR participation in methadone, naloxone, or buprenorphine treatment program (past 6 months)

More information

Acknowledgements Table of Contents Introductory Letter by Jessica Danforth Introduction to the Manual

Acknowledgements Table of Contents Introductory Letter by Jessica Danforth Introduction to the Manual Index Acknowledgements Table of Contents Introductory Letter by Jessica Danforth Introduction to the Manual i iii vii viii Chapter 1: Introduction Klinic 1 Teen Talk 2 Operating Principles 4 Facilitation101

More information

HIV Pre-Exposure Prophylaxis (PrEP)

HIV Pre-Exposure Prophylaxis (PrEP) HIV Pre-Exposure Prophylaxis (PrEP) A Crash Course For General Practitioners Vincent Cornelisse BSc(Hons) MBBS FRACGP FAChSHM(RACP) Sexual Health Physician Prahran Market Clinic & Melbourne Sexual Health

More information

Roy M. Gulick, MD, MPH Chief, Division of Infectious Diseases Professor of Medicine Weill Medical College of Cornell University New York City

Roy M. Gulick, MD, MPH Chief, Division of Infectious Diseases Professor of Medicine Weill Medical College of Cornell University New York City PrEP 2013 Roy M. Gulick, MD, MPH Chief, Division of Infectious Diseases Professor of Medicine Weill Medical College of Cornell University New York City Slide #2 U.S.: New HIV Infections Per Year ~50,000

More information

Biomedical HIV Prevention & PrEP Pre exposure Prophylaxis 2013

Biomedical HIV Prevention & PrEP Pre exposure Prophylaxis 2013 Biomedical HIV Prevention & PrEP Pre exposure Prophylaxis 2013 Community Education Team The AIDS Institute/AIDS Alliance Be the Generation to End the AIDS Epidemic bethegeneration.nih.gov www.aids-alliance.org/education/vaccine

More information

Tobin L. Brown, RN, BScN, ACRN March 16, 2012

Tobin L. Brown, RN, BScN, ACRN March 16, 2012 Tobin L. Brown, RN, BScN, ACRN March 16, 2012 New treatment guidelines New medications PrEP update Research findings Aging Mathematical calculation, like pack years for smoking created by AIDS Research

More information

If you are a man that ONLY has sex with women this may not be the brochure for you.

If you are a man that ONLY has sex with women this may not be the brochure for you. If you are a man that ONLY has sex with women this may not be the brochure for you. To find resources that best meet your needs check out the following website: http://www.cdc.gov/men Whether you are gay,

More information

REVIEW OF PREP GUIDELINES: A PRIMER FOR THE PRIMARY CARE PRACTITIONER ANTONIO E. URBINA, MD. PrEP Webinar Series

REVIEW OF PREP GUIDELINES: A PRIMER FOR THE PRIMARY CARE PRACTITIONER ANTONIO E. URBINA, MD. PrEP Webinar Series REVIEW OF PREP GUIDELINES: A PRIMER FOR THE PRIMARY CARE PRACTITIONER ANTONIO E. URBINA, MD PrEP Webinar Series Disclosure Speaker s Bureau: Gilead, VIIV, BMS, Merck, Serono LEARNING OBJECTIVES: 1. Review

More information

Case Studies in PrEP Management. Kevin L. Ard, MD, MPH Massachusetts General Hospital, National LGBT Health Education Center April 15, 2016

Case Studies in PrEP Management. Kevin L. Ard, MD, MPH Massachusetts General Hospital, National LGBT Health Education Center April 15, 2016 Case Studies in PrEP Management Kevin L. Ard, MD, MPH Massachusetts General Hospital, National LGBT Health Education Center April 15, 2016 Continuing Medical Education Disclosure Program Faculty: Kevin

More information

Arizona State Office of Rural Health Webinar Series

Arizona State Office of Rural Health Webinar Series Arizona State Office of Rural Health Webinar Series Mute your phone &/or computer microphone Time is reserved at the end for Q&A Please fill out the post-webinar survey Webinar is being recorded Recording

More information

HIV Prevention Pearls

HIV Prevention Pearls HIV Prevention Pearls Meghan Rothenberger, MD Assistant Professor Division of Infectious Diseases University of Minnesota Director, Youth and AIDS Projects October 27, 2017 Disclosure Information I have

More information

MANAGEMENT OF SEXUAL EXPOSURE TO HIV: PEPSE

MANAGEMENT OF SEXUAL EXPOSURE TO HIV: PEPSE Sandyford Protocols MANAGEMENT OF SEXUAL EXPOSURE TO HIV: PEPSE www.hiv-druginteractions.org If you require information on occupational exposure to blood borne viruses, including HIV, please refer to the

More information

NEW CANADIAN. GUIDELINES: Public health and community perspectives. Camille Arkell, Moderator Dr. Darrell Tan, Gilles Charette, Dr.

NEW CANADIAN. GUIDELINES: Public health and community perspectives. Camille Arkell, Moderator Dr. Darrell Tan, Gilles Charette, Dr. NEW CANADIAN HIV PrEP/nPEP GUIDELINES: Public health and community perspectives PRESENTED BY Camille Arkell, Moderator Dr. Darrell Tan, Gilles Charette, Dr. Joss Reimer May 16, 2018 Webinar Agenda (1 hour)

More information

PrEP Guidelines for the Ob/Gyn. Outline. 1. How many patient have you discussed PrEP with this year?

PrEP Guidelines for the Ob/Gyn. Outline. 1. How many patient have you discussed PrEP with this year? PrEP Guidelines for the Ob/Gyn Megan J. Huchko, MD, MPH Obstetrics and Gynecology Update October 14, 2015 I have no financial or other conflicts of interest to declare Outline The Need for PrEP: HIV Treatment

More information

Viral Load Suppression/Any HIV Care 84%

Viral Load Suppression/Any HIV Care 84% 1 2 Viral Load Suppression/Any HIV Care 84% 3 Key Policy Advancements 4 Implementati on of 30% rent cap affordable housing project Expansion of data sharing Elimination of written consent for HIV Testing

More information

Assessing PrEP Capacity, Processes, and Technical Assistance in Local Health Departments throughout Michigan. Jessica N. Miller

Assessing PrEP Capacity, Processes, and Technical Assistance in Local Health Departments throughout Michigan. Jessica N. Miller Assessing PrEP Capacity, Processes, and Technical Assistance in Local Health Departments throughout Michigan Jessica N. Miller Presented to the Public Health Faculty at the University of Michigan-Flint

More information

Re: Revisions to the Communicable Disease Control Manual, Chapter 3- Infection Control

Re: Revisions to the Communicable Disease Control Manual, Chapter 3- Infection Control 1 February 27, 2009 ATTN: Medical Health Officers and Branch Offices Public Health Nursing Administrators and Assistant Administrators Holders of Communicable Disease Control Manuals Re: Revisions to the

More information

Comprehensive Epi Update: HIV, AIDS and STI Mark Gilbert, MD

Comprehensive Epi Update: HIV, AIDS and STI Mark Gilbert, MD Comprehensive Epi Update: HIV, AIDS and STI Mark Gilbert, MD February 2014 Objectives Recognize importance of disease syndemics To review current provincial trends: HIV AIDS Infectious syphilis Chlamydia

More information

PrEP Implementation in San Francisco. Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health

PrEP Implementation in San Francisco. Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health PrEP Implementation in San Francisco Michael Barajas- Citywide PrEP Navigator San Francisco City Clinic San Francisco Department of Public Health Why are new prevention strategies needed? New infections

More information

Program to control HIV/AIDS

Program to control HIV/AIDS 90-90-90 Program to control HIV/AIDS Hamid Sharifi Associate Professor in Epidemiology [sharifihami@gmail.com] 1 Targets for ending the AIDS epidemic 2 New HIV infections in low- and middle-income countries,

More information